FDA 483 - VMP COSMETICS - July 13, 2022

VMP Cosmetics, an OTC drug manufacturer in Vernon, CA, received six observations during an FDA inspection. The firm demonstrated significant deficiencies across multiple systems, including failures in quality control unit responsibilities, annual product reviews, control of rejected materials, and access to labeling. Additionally, the inspection found issues with raw material identity testing and the adequacy of the stability program's test methods.